Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 6.59%11.9B | 2.53%11.17B | -10.65%10.89B | -10.20%12.19B | 13.01%13.57B | -5.95%12.01B | -10.06%12.77B | 13.17%14.2B | -14.04%12.55B | 3.76%14.6B |
Net profit before non-cash adjustment | 33.23%17.06B | -0.97%12.8B | 17.69%12.93B | 0.19%10.99B | -5.89%10.96B | 2.83%11.65B | -11.57%11.33B | 18.40%12.81B | -23.65%10.82B | -2.26%14.17B |
Total adjustment of non-cash items | -88.66%-3.33B | 4.13%-1.76B | -1,282.71%-1.84B | -166.00%-133M | -104.54%-50M | -3.76%1.1B | 162.39%1.14B | -77.20%436M | 278.03%1.91B | -195.64%-1.07B |
-Depreciation and amortization | 3.99%547M | 3.95%526M | 1.00%506M | -0.40%501M | -1.95%503M | 0.79%513M | -7.96%509M | -9.05%553M | 11.15%608M | 3.21%547M |
-Reversal of impairment losses recognized in profit and loss | --322M | --0 | ---- | ---- | -81.88%185M | --1.02B | ---- | --130M | ---- | ---- |
-Disposal profit | -167.58%-1.67B | -191.12%-623M | 31.85%-214M | 39.03%-314M | -23.80%-515M | -65.08%-416M | 21.25%-252M | 8.31%-320M | -76.26%-349M | -38.46%-198M |
-Net exchange gains and losses | -69.98%-3.42B | 5.76%-2.01B | -268.74%-2.14B | -181.55%-579M | 211.11%710M | -205.97%-639M | 2,512.00%603M | -101.72%-25M | 176.98%1.46B | -159.97%-1.89B |
-Other non-cash items | 157.80%892M | 8,550.00%346M | -98.46%4M | 127.76%259M | -250.00%-933M | 119.01%622M | 189.80%284M | -50.51%98M | -57.60%198M | -68.08%467M |
Changes in working capital | -1,553.17%-1.83B | 163.64%126M | -114.80%-198M | -49.59%1.34B | 456.24%2.65B | -351.69%-745M | -68.78%296M | 601.59%948M | -112.60%-189M | 196.53%1.5B |
-Change in receivables | 28.56%-1.1B | -54.16%-1.54B | -212.78%-997M | -58.77%884M | 283.25%2.14B | -285.42%-1.17B | -19.41%631M | 243.93%783M | -117.89%-544M | 218.84%3.04B |
-Change in inventory | 5.22%-254M | 71.06%-268M | -198.30%-926M | 332.11%942M | 235.40%218M | -175.23%-161M | 272.58%214M | -212.73%-124M | -86.20%110M | 11,485.71%797M |
-Change in payables | -145.26%-897M | 30.48%1.98B | 521.94%1.52B | -262.16%-360M | -48.37%222M | 191.30%430M | -385.45%-471M | -23.96%165M | 111.33%217M | -342.41%-1.92B |
-Provision for loans, leases and other losses | 919.61%418M | -124.76%-51M | 260.94%206M | -282.86%-128M | -55.13%70M | 300.00%156M | -162.90%-78M | 342.86%124M | 106.64%28M | -290.95%-422M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -3.33%-31M | -25.00%-30M | 4.00%-24M | 24.24%-25M | -266.67%-33M | -12.50%-9M | 20.00%-8M | 58.33%-10M | -140.00%-24M | 9.09%-10M |
Interest received (cash flow from operating activities) | 314.98%1.36B | 57.21%327M | -48.89%208M | -23.50%407M | 92.06%532M | -6.42%277M | 1.02%296M | -12.80%293M | 68.84%336M | 43.17%199M |
Tax refund paid | 5.94%-4.05B | -29.09%-4.31B | -10.49%-3.34B | 22.16%-3.02B | -27.20%-3.88B | 31.42%-3.05B | -43.47%-4.45B | 23.17%-3.1B | 35.11%-4.04B | -27.38%-6.22B |
Other operating cash inflow (outflow) | 0 | -1M | 0 | 0.00%-1M | 0.00%-1M | -1M | 0 | 0 | 0 | -1M |
Operating cash flow | 28.26%9.18B | -7.54%7.15B | -18.98%7.74B | -6.29%9.55B | 10.45%10.19B | 7.17%9.23B | -24.36%8.61B | 28.99%11.38B | 3.01%8.82B | -8.03%8.57B |
Investing cash flow | ||||||||||
Net investment product transactions | 56.07%-8.94B | -105.78%-20.34B | -1,003.35%-9.89B | 3.97%-896M | 91.43%-933M | -498.39%-10.89B | -57.17%2.73B | 384.51%6.38B | 126.48%1.32B | -33.07%-4.97B |
Net changes in other investments | -210.89%-628M | -494.12%-202M | 94.95%-34M | -122.11%-673M | -965.71%-303M | 109.43%35M | 37.65%-371M | 4.49%-595M | 62.78%-623M | -119.97%-1.67B |
Investing cash flow | 53.45%-9.56B | -107.11%-20.55B | -532.25%-9.92B | -26.94%-1.57B | 88.61%-1.24B | -559.48%-10.85B | -59.18%2.36B | 733.72%5.79B | 110.44%694M | -47.78%-6.65B |
Financing cash flow | ||||||||||
Net issuance payments of debt | --0 | -216.04%-123M | 213.98%106M | -196.88%-93M | 420.00%96M | ---30M | --0 | --0 | --1B | --0 |
Net common stock issuance | --0 | --0 | --0 | --0 | ---3M | --0 | 42.27%-112M | 91.18%-194M | -123.12%-2.2B | 38.95%-986M |
Cash dividends paid | 0.09%-1.08B | 0.00%-1.08B | -14.09%-1.08B | -0.11%-944M | -7.77%-943M | 0.23%-875M | 0.00%-877M | 1.46%-877M | -7.62%-890M | -6.71%-827M |
Net other fund-raising expenses | -8.28%-157M | -20.83%-145M | -1.69%-120M | -35.63%-118M | ---87M | ---- | ---1M | ---- | ---- | ---1M |
Financing cash flow | 8.33%-1.23B | -23.28%-1.35B | 5.54%-1.09B | -23.27%-1.16B | -3.54%-937M | 8.59%-905M | 7.56%-990M | 48.76%-1.07B | -15.21%-2.09B | 27.61%-1.81B |
Net cash flow | ||||||||||
Beginning cash position | -19.08%58.78B | -3.12%72.64B | 10.10%74.97B | 12.49%68.1B | -3.42%60.54B | 17.86%62.68B | 42.13%53.18B | 22.84%37.42B | 2.06%30.46B | 10.41%29.85B |
Current changes in cash | 89.00%-1.62B | -350.09%-14.74B | -147.97%-3.27B | -14.87%6.83B | 416.63%8.02B | -125.37%-2.53B | -37.99%9.98B | 116.72%16.1B | 7,041.35%7.43B | -95.50%104M |
Effect of exchange rate changes | -1.71%861M | -6.61%876M | 1,605.45%938M | 112.04%55M | -217.78%-457M | 180.67%388M | -44.01%-481M | 28.94%-334M | -192.16%-470M | 0.79%510M |
Cash adjustments other than cash changes | ---- | 200.00%1M | 0.00%-1M | ---1M | ---- | ---- | ---- | ---- | ---1M | ---- |
End cash Position | -1.29%58.02B | -19.08%58.78B | -3.12%72.64B | 10.10%74.97B | 12.49%68.1B | -3.42%60.54B | 17.86%62.68B | 42.13%53.18B | 22.84%37.42B | 2.06%30.46B |
Free cash flow | 28.26%9.18B | -7.54%7.15B | -18.98%7.74B | -6.29%9.55B | 10.45%10.19B | 7.17%9.23B | -24.36%8.61B | 28.99%11.38B | 3.01%8.82B | -8.03%8.57B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |